Conference call scheduled for March 13, 2008 at 1:30 p.m. (Pacific);
simultaneous webcast at http://www.adventrx.com
SAN DIEGO, March 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals,
Inc. (Amex: ANX) today announced that it will host a conference call and
webcast on Thursday, March 13th, 2008 at 1:30 p.m. Pacific / 4:30 p.m.
Eastern to discuss fourth quarter and year end 2007 results. Evan M.
Levine, chief executive officer and president of ADVENTRX, will host the
conference call.
The conference call may be accessed by dialing (800) 896-8445 for
domestic callers and (785) 830-1916 for international callers. The webcast
will be available live via the Internet by accessing ADVENTRX's web site at
http://www.adventrx.com under "Investors". Replays of the webcast will be
available for 30 days on ADVENTRX's web site, and a phone replay will be
available through March 18, 2008 by dialing (888) 203-1112 and entering the
passcode 3804583.
About ADVENTRX Pharmaceuticals
ADVENTRX Pharmaceuticals is a biopharmaceutical research and
development company focused on commercializing proprietary product
candidates for the treatment of cancer and infectious diseases. The Company
seeks to improve the performance and safety of existing treatments by
addressing significant problems, such as drug metabolism and
bioavailability, excessive toxicity and treatment resistance. More
information can be found on ADVENTRX's web site at http://www.adventrx.com.
SOURCE ADVENTRX Pharmaceuticals
 back to top
Related links:
http://www.adventrx.com
CONTACT:
Investors, Ioana C. Hone of ADVENTRX
Pharmaceuticals, +1-858-552-0866
|
